Access to breast-conserving therapy still an issue for some patients
the ONA take:
According to a new study published in JAMA Surgery, researchers at The University of Texas MD Anderson Cancer Center in Houston, Texas, have found that the rates of breast-conserving therapy for early-stage breast cancer have increased, but access to this treatment modality still remains an issue for some patients.
For the study, researchers analyzed data from approximately 728,000 women with stage T1 or T2 breast cancer treated between 1998 and 2011 from the National Cancer Data Base. Researchers found that the proportion of patients undergoing breast-conserving therapy increased from 54.3% in 1998 to 59.7% in 2006, and leveled off at 60.1% in 2011.
Results showed that certain demographic factors, such as insurance, income, and travel distance to treatment facilities, impact which patients have access to breast-conserving therapy; however, declines in disparities related to age, geographic region, and treatment facility type were also observed.
The findings suggest that the majority of women are opting for breast-conserving therapy, but various disparities still exist that limit access to that treatment approach.
Rates of breast-conserving therapy for early-stage breast cancer have increased.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Mammograms (Fact Sheet)
- Tissue Biobank Procurement Consent Should Include Discussion of Confidentiality Risks
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|